Skip to main content
Google Tag Manager
P&T COMMUNITY
Register
Sign in
Search form
Search
News
Approvals, Launches, & New Indications
Pipeline Plus
Research News
Industry Trends
Safety Issues
Agency Actions
Health Care Reform
Guidelines
Clinical Trials
P&T
Current issue
Past issues
Contact us
Digital Edition
Subscribe
P&T TV
Dr. David B. Nash
Meeting Reports
Health Care & Law
Drug Forecast
More
Meeting Highlights
Medication Errors
Prescription: Washington
Authors
About
Contact Us
News
P&T Journal
Formulary Kits
INGREZZA®
(valbenazine) tablets
JAKAFI®
ruxolitinib (tablets)
KEDRAB™
(Rabies Immune Globulin [Human])
LOKELMA™
(sodium zirconium cyclosilicate) 10 g for oral suspension
PERSERIS™
(risperidone) for extended-release injectable suspension
ZULRESSO™
(brexanolone) injection CIV
You are here
Home
News by month %2 2015
News by month February 2015
PTCommunity News February 2015
Five Things to Know About Supreme Court Case Challenging Affordable Care Act
FDA Approves Ebola Test for Emergency Use
Daclatasvir/Sofosbuvir Combo Shows Promise in Hepatitis C Patients Co-Infected With HIV
CDC Committee Reaffirms Recommendation for Annual Influenza Vaccination
Surgeon Suggests Ways to Perform Human Head Transplants
Supreme Court Decision on Insurance Subsidies Could Trigger Price Spikes
FDA Approves Antibacterial Drug Avycaz (Ceftazidime/Avibactam)
Once-Daily Basal Insulin Toujeo Wins FDA Nod
Report: Competition Among Physicians and Retail Clinics Drives Up Antibiotic Prescribing Rate
Cystic Fibrosis Discovery May Lead to New Treatment Strategy
FDA Accepts New Drug Application for Extended-Release Hydrocodone Tablets With Abuse-Deterrence Technology
Could HIV Drug Beat Strep Throat, Flesh-Eating Bacteria?
Researchers Test ‘Breakthrough’ Pediatric Leukemia Treatment
Nationwide Recall of Atracurium Besylate Injection
Eribulin (Halaven) Improves Survival in Sarcoma Study
Fancy Flourishes at Hospitals Don’t Impress Patients, Study Finds
Farydak (Panobinostat) Gets FDA Nod for Treatment of Multiple Myeloma
Opioid Pain Reliever Abuse Called Top Public Health Challenge
Quick Test for Ebola Virus
Inhaled Dry-Powder Vancocymcin (AeroVanc) Reduces MRSA in Cystic Fibrosis Patients
Obama Administration Disallows Health Plans Without Hospital Coverage
CDC Issues Measles Advisory
FDA Approves Closure System to Permanently Treat Varicose Veins
Asthma Drug Tiotropium Improves Lung Function in Phase III Trials
Positive Results Reported for Oral Semaglutide in Diabetes Patients
Safety and Efficacy of Statins Have Been Exaggerated, Scientists Say
FDA Warning: Duodenoscope Design May Impede Effective Cleaning
First Direct-to-Consumer Genetic Test for Rare Disorder Wins FDA Nod
Study: Women With Multiple Sclerosis May Have Lower Levels of Key Nutrients
Gilead Has Effective HIV Pill, But Few People Know About It
‘Superbug’ Linked to Two Deaths at UCLA Hospital; 100 Potentially Exposed
Scientists Develop Anti-HIV Agent Powerful Enough to Work in a Vaccine
Stanford Study Shows Rural Disadvantages Under Affordable Care Act
New Nanogel for Drug Delivery
Ranibizumab (Lucentis) Reverses Vision Loss Caused by Diabetes
CVS Concerned About Potential Impact of New Cholesterol Drugs on Health Care System
FDA Approves New Use for Cancer Drug Lenalidomide (Revlimid)
Science Behind Commonly Used Antidepressants Appears to Be Backwards, Researchers Say
Positive Results Reported for Eliglustat (Cerdelga) in Treatment-Naïve Patients With Gaucher Disease Type 1
Generic Lovenox and Generic Zyvox Launched in U.S.
Company Resubmits Women’s Libido Pill to FDA
New Therapeutic Target for Multiple Sclerosis
Alirocumab Lowers LDL-Cholesterol in Phase III Study
FDA Grants Priority Review to Heart Failure Treatment
Lung Cancer Drug Motesanib Fails Late-Stage Trial
Popular Painkiller Ketorolac in Short Supply at Hospitals After Recall
FDA Approves Lenvatinib (Lenvima) for Thyroid Cancer
Oral Eliglustat (Cerdelga) Scores in Treatment of Gaucher’s Disease
Study Identifies Patients at Higher Risk of Second Stroke
Promising Results for New Alzheimer’s Therapy
2015 Could Be 'Year of the Health Care Hack,' Experts Warn
JAMA Editorial Questions Medicare’s Approach to Tying Hospital Quality Measurement to Financial Penalties
FDA Advisory Committees to Review Talimogene Laherparepvec for Metastatic Melanoma
Tobacco May Cause More Deaths than Currently Estimated
Making a Better Wound Dressing — With Fish Skin
Company Clears Up Exparel-Related FDA Warning Letter
New Stroke VTE Safety Recommendations
FDA Approves Finafloxacin Otic Suspension
Reolysin Receives ‘Orphan Drug’ Designation for Ovarian Cancer
A New Name for Chronic Fatigue Syndrome?
Oral Ixazomib Improves Survival in Late-Stage Myeloma Trial
Young Companies Look to Shake Up Global Glaucoma Market
Drug Combo Kills Hepatitis C Virus Within 6 Weeks
FDA Reviews Possible Risks of Pain Medications During Pregnancy
Predicting Disability and Death After the ICU
FDA Clears System to Reduce Stroke Risk During Stent and Angioplasty Procedures
Drug Combination Knocks Out HCV in Six Weeks During Phase II Trial
Many Mastectomy Patients With Locally Advanced Breast Cancer Do Not Get Post-Op Radiation
Gene Therapy Market Could Reach $13 Billion in 10 Years, Report Says
Lucentis Approved to Treat Diabetic Retinopathy in Patients With Diabetic Macular Edema
CMS Approves Medicare Coverage for Lung Cancer Screening
After Hospital Discharge, Deadly Heart Risks Can Remain for Up to a Year
Dabrafenib/Tametinib Improves Survival in Phase III Melanoma Study
Coffee Intake May Lower Endometrial Cancer Risk
Fast-Acting Human Insulin, HinsBet, Shows Promise in Mid-Stage Trial
Study: Unnecessary Antibiotics Often Prescribed for Respiratory Infections in Outpatient Settings
Tiny Robotic ‘Hands’ Could Improve Cancer Diagnostics, Drug Delivery
More Expensive Emergency Care Yields Better Results
Free From Ebola, Survivors Complain of New Syndrome
FDA Approves First Tissue Adhesive for Internal Use
Medical Debt Still a Problem Under Affordable Care Act
Company Announces New Class of Agents for Cystic Fibrosis
FDA Approves Breast Cancer Drug Ibrance (Palbociclib)
Biosimilar Candidate Is Equivalent to Adalimumab in Phase III Arthritis Trial
CDC Report: 58 Million Nonsmokers in U.S. Are Still Exposed to Secondhand Smoke
Reducing Hospital Readmission Rates Will Require Community-Focused Efforts
Sanofi Launches Only Inhaled Insulin for Diabetics
Cost of Having Diabetes Has Doubled in Two Decades
Study: Metformin May Lower Lung Cancer Risk in Diabetic Nonsmokers
‘Smart’ Devices Track Hand-Washing in Hospitals to Help Reduce Spread of Infection
FDA Approves Pazeo (Olopatadine) Solution for Ocular Allergy Itch Relief
HHS Issues ‘Road Map’ for Improving Electronic Health Information
FDA Expands Use of Vyvanse (Lisdexamfetamine) to Include Treatment of Binge-Eating Disorder
Glyxambi (Empagliflozin/Linagliptin) Wins FDA Nod for Treatment of Type-2 Diabetes in Adults
FDA Approves Aromasin for Adjuvant Treatment of Early Breast Cancer in Postmenopausal Women
Candesartan Cilexetil Gains New Indication for the Treatment of Heart Failure
